EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Bronchiectasis on Healthcare Resource Utilization and Direct Medical Costs of Managing Comorbid Chronic Obstructive Pulmonary Disease, Asthma, and Rheumatoid Arthritis in the United States

Maitreyee Mohanty, Fei Tang, John Fastenau, Joseph Feliciano, Melanie Lauterio, Sebastian Fucile, Mahroz Haider, Ruxana T Sadikot

The Clinical Respiratory Journal · 2025

DOI: 10.1111/crj.70150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2025. Verfasst von Maitreyee Mohanty und 7 weiteren Autor:innen. Beteiligte Einrichtung: Insmed Incorporated, Bridgewater, New Jersey, USA. Hauptthemen laut MEDLINE: Bronchiectasis, Arthritis, Rheumatoid, Asthma, Pulmonary Disease, Chronic Obstructive. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, Insmed Incorporated.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although patients with bronchiectasis often have comorbidities, the impact of bronchiectasis on managing these is unknown. This study assessed the incremental burden of managing chronic obstructive pulmonary disease (COPD), asthma, and rheumatoid arthritis in patients with bronchiectasis.

Methods

This retrospective cohort study using Merative MarketScan US claims data included patients with a COPD, asthma, or rheumatoid arthritis diagnosis between January 2017 and December 2021. Within these cohorts, patients with a bronchiectasis diagnosis (excluding cystic fibrosis) were compared with nonbronchiectasis controls following 1:1 propensity score matching (1:2 for rheumatoid arthritis). Comorbid disease‐specific inpatient, outpatient, and emergency room (ER) visits and direct medical costs were reported.

Results

After matching, 4291 patients with COPD, 2460 with asthma, and 566 with rheumatoid arthritis, all with bronchiectasis, and the corresponding controls, were included. For patients with COPD, proportions with COPD‐related outpatient (66.5% vs. 56.8%), ER (7.5% vs. 5.8%), and inpatient visits (4.5% vs. 3.1%), as well as respiratory‐related ($11 054 vs. $6961) and disease‐specific ($1384 vs. $1107) costs were significantly higher in the bronchiectasis cohort (vs. control cohort). For patients with asthma, asthma‐related outpatient visits (52.0% vs. 41.1%), respiratory‐related ($10 327 vs. $5458), and disease‐specific ($489 vs. $221) costs were significantly higher in the bronchiectasis cohort. For patients with rheumatoid arthritis, rheumatoid arthritis‐specific PPPY outpatient (5.1 vs. 3.9) and specialist visits (3.5 vs. 2.5), and disease‐specific ($4820 vs. $2592) costs were significantly higher in the bronchiectasis cohort ( p < 0.05 for all comparisons).

Conclusions

Bronchiectasis is associated with higher comorbid disease‐related healthcare resource utilization and costs and complicates the management of comorbid conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchiectasisArthritis, RheumatoidAsthmaPulmonary Disease, Chronic ObstructivePatient Acceptance of Health CareHealth Care CostsHealth ResourcesHumansMaleFemaleUnited StatesRetrospective StudiesMiddle AgedComorbidityAgedAdultHospitalizationPropensity Score

Stichwörter der Autor:innen

COPDasthmabronchiectasiscomorbidityhealth care costsretrospective studyrheumatoid arthritis

Autor:innen und Institutionen

  • Insmed Incorporated, Bridgewater, New Jersey, USA.
  • Cytel, Waltham, Massachusetts, USA.
  • University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • VA Nebraska Iowa Healthcare System, Omaha, Nebraska, USA.

Förderung

  • BLRD VA
  • Insmed Incorporated

Zitieren

APA

Mohanty, M., Tang, F., Fastenau, J., Feliciano, J., Lauterio, M., Fucile, S., Haider, M., & Sadikot, R. T. (2025). Impact of Bronchiectasis on Healthcare Resource Utilization and Direct Medical Costs of Managing Comorbid Chronic Obstructive Pulmonary Disease, Asthma, and Rheumatoid Arthritis in the United States. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70150

Vancouver

Mohanty M, Tang F, Fastenau J, Feliciano J, Lauterio M, Fucile S, et al. Impact of Bronchiectasis on Healthcare Resource Utilization and Direct Medical Costs of Managing Comorbid Chronic Obstructive Pulmonary Disease, Asthma, and Rheumatoid Arthritis in the United States. The Clinical Respiratory Journal. 2025. doi:10.1111/crj.70150

BibTeX
@article{Mohanty2025,
  author = {Mohanty, Maitreyee and Tang, Fei and Fastenau, John and Feliciano, Joseph and Lauterio, Melanie and Fucile, Sebastian and Haider, Mahroz and Sadikot, Ruxana T},
  title = {Impact of Bronchiectasis on Healthcare Resource Utilization and Direct Medical Costs of Managing Comorbid Chronic Obstructive Pulmonary Disease, Asthma, and Rheumatoid Arthritis in the United States},
  journal = {The Clinical Respiratory Journal},
  year = {2025},
  doi = {10.1111/crj.70150}
}
Kostenlos starten →